Senior Leadership

项目总结（见说明）： Winship的高级领导层共同组成了其执行委员会，这是癌症中心的主要决策机构。在过去的十年里，高级领导层已经聚集在一起，其使命是确定Winship的科学优先事项，并监督其实施。该小组由小沃尔特·J·柯伦领导，医学博士，2009年9月被任命为Winship执行董事。Curran博士是一位非常有成就的癌症医生和研究人员，对所有癌症相关研究具有广泛的权威， 埃默里大学的临床和教育活动。他领导了Winship的全面战略计划的制定，并将50%的时间用于Winship的领导和癌症中心支持补助金（CCSG）的管理。2009年10月，Curran博士任命Fadlo R. Khuri，医学博士，作为Winship的副主任，职责包括代表主要大学的中心主任 和保健功能，并侧重于科学的成功和研究计划的交叉施肥。 博士柯伦组建了一个高效的团队，其中包括黛安·卡塞尔，硕士，执行主任;保罗W. Doetsch博士，基础研究副主任;沃勒医学博士，哲学博士、临床研究副总监; Kimberiy Kerstann，Ph.D.，研究管理副主任;约瑟夫·利普斯科姆博士，人口科学副主任;最近，黛博拉W。布鲁纳博士，R.N.，成果研究副主任。要求为所有方面提供支助， 上述人员与其CCSG职责相符。此外，Rein Saral，医学博士，一个有成就的医生领导，担任副主任社区事务和推广，查尔斯斯特利，医学博士，一位全国著名的外科肿瘤学家担任临床事务副主任，Shin，医学博士，一个非常有成就的物理学家，科学家，是学术发展副主任。这些人得到机构资金的支持，不需要CCSG资金。 该小组每月举行两次会议，作为主要的审议机构，就包括Winship的资金、空间和其他资源分配在内的重大问题向执行主任提供咨询意见。Winship的高级领导层支持了大量大型多研究者赠款的开发，包括头颈癌SPORE赠款，几个P01，一个大型NASA中心赠款，以及埃默里大学被指定为NCI化学生物学联盟的成员。

PROJECT SUMMARY (See instructions): Winship's senior leadership together constitutes Its Executive Committee, the major decision-making body of the cancer center. The senior leadership has been assembled over the last decade, with a mission to define Winship's scientific priorities and provide oversight to their implementation. The group is led by Walter J. Curran, Jr., M.D., who was appointed Winship Executive Director in September 2009. Dr. Curran, a highly accomplished cancer physician and researcher, has broad authority over all cancer-related research, clinical and educational activities at Emory University. He led the development of a comprehensive strategic plan for Winship and devotes 50% of his time to Winship leadership and the administration of the Cancer Center Support Grant (CCSG). In October 2009, Dr. Curran appointed Fadlo R. Khuri, M.D., as Deputy Director of Winship, with responsibilities defined to include representing the center director at major university and health care functions and focusing on the scientific success and cross-fertilization of the research programs. Dr. Curran has assembled a highly effective team that includes Diane Cassels, M.S., Executive Administrator; Paul W. Doetsch, Ph.D., Associate Director for Basic Research; Edmund K. Waller, M.D., Ph.D., Associate Director for Clinical Research; Kimberiy Kerstann, Ph.D., Associate Director for Research Administration; Joseph Lipscomb, Ph. D., Associate Director for Population Sciences; and most recently, Deborah W. Bruner, Ph.D., R.N., Associate Director for Outcomes Research. Support is requested for all of the above individuals commensurate with their CCSG responsibilities. In addition, Rein Saral, M.D., an accomplished physician leader, serves as Associate Director for Community Affairs and Outreach, Charles Staley, M.D., a nationally prominent surgical oncologist serves as Associate Director for Clinical Affairs, and Dong M. Shin, M.D., a highly accomplished physician-scientist, is Associate Director for Academic Development. These individuals are supported by institutional funds, and no CCSG funds are requested. This group meets twice monthly and serves as the primary deliberative body that advises the Executive Director on major issues including the allocation of Winship's funds, space, and other resources. The Winship senior leadership has supported the development of a significant number of large multi-investigator grants, including a Head and Neck Cancer SPORE grant, several P01's, a large NASA center grant, and Emory's designation as a member of the NCI Chemical Biology Consortium.